Media

Jiaxing Municipal Party Committee Secretary Chen Wei Visits Angel Pharmaceuticals for Inspection and Guidance

Jiaxing Municipal Party Committee Secretary Chen Wei Visits Angel Pharmaceuticals for Inspection and Guidance

2023-10-11

Jiaxing Municipal Party Committee Secretary Chen W...

Angel Pharmaceuticals Presents Latest Research Findings from CPI-818 Clinical Trial at the 17th International Conference on Malignant Lymphoma (ICML) 2023

Angel Pharmaceuticals Presents Latest Research Findings from CPI-818 Clinical Trial at the 17th International Conference on Malignant Lymphoma (ICML) 2023

2023-06-16

Angel Pharmaceuticals Presents Latest Research Fin...

Zhejiang Provincial Vice Governor Zhang Yanyun Visits Angel Pharmaceuticals for Inspection and Guidance

Zhejiang Provincial Vice Governor Zhang Yanyun Visits Angel Pharmaceuticals for Inspection and Guidance

2023-05-10

Zhejiang Provincial Vice Governor Zhang Yanyun Vis...

Angel Pharmaceuticals Presents Latest Translational Research Findings on CPI-818 (ITK Inhibitor) at the 2023 AACR Annual Meeting

Angel Pharmaceuticals Presents Latest Translational Research Findings on CPI-818 (ITK Inhibitor) at the 2023 AACR Annual Meeting

2023-04-14

Angel Pharmaceuticals Presents Latest Translationa...

Angel Pharmaceuticals Announces First Patient Dosed in China in Phase I/Ib Clinical Trial of Anti-CD73 Monoclonal Antibody Mupadolimab

Angel Pharmaceuticals Announces First Patient Dosed in China in Phase I/Ib Clinical Trial of Anti-CD73 Monoclonal Antibody Mupadolimab

2023-02-28

Angel Pharmaceuticals Announces First Patient Dose...

Angel Pharmaceuticals Presents Latest Data from Phase I/Ib Clinical Trial of CPI-818 (ITK Inhibitor) at the 64th ASH Annual Meeting

Angel Pharmaceuticals Presents Latest Data from Phase I/Ib Clinical Trial of CPI-818 (ITK Inhibitor) at the 64th ASH Annual Meeting

2022-12-13

Angel Pharmaceuticals Presents Latest Data from Ph...

Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

2022-09-27

Angel Pharmaceuticals Announces Approval of IND Ap...

Patient Recruitment Advertisement

Patient Recruitment Advertisement

2022-04-07

Patient Recruitment Advertisement

Angel Pharmaceuticals Appoints Dr. Erik J. Verner, Ph.D., as Senior Vice President

Angel Pharmaceuticals Appoints Dr. Erik J. Verner, Ph.D., as Senior Vice President

2022-03-17

Angel Pharmaceuticals Appoints Dr. Erik J. Verner,...